CU23257A1 - COMPOSICIONES VACUNALES A BASE DE GANGLIOSIDOS PARA LA ADMINISTRACION SUBCUTáNEA - Google Patents

COMPOSICIONES VACUNALES A BASE DE GANGLIOSIDOS PARA LA ADMINISTRACION SUBCUTáNEA

Info

Publication number
CU23257A1
CU23257A1 CU20030047A CU20030047A CU23257A1 CU 23257 A1 CU23257 A1 CU 23257A1 CU 20030047 A CU20030047 A CU 20030047A CU 20030047 A CU20030047 A CU 20030047A CU 23257 A1 CU23257 A1 CU 23257A1
Authority
CU
Cuba
Prior art keywords
subcutaneous administration
vaccine compositions
gangliosid
based vaccine
compositions
Prior art date
Application number
CU20030047A
Other languages
English (en)
Inventor
Molina Luis Enrique Fernandez
Pardillo Circe Mesa
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Priority to CU20030047A priority Critical patent/CU23257A1/es
Priority to ARP040100571A priority patent/AR043377A1/es
Priority to PE2004000186A priority patent/PE20040955A1/es
Priority to TW093104808A priority patent/TWI344372B/zh
Priority to CL200400374A priority patent/CL2004000374A1/es
Priority to MYPI20040641A priority patent/MY139811A/en
Priority to UY28207A priority patent/UY28207A1/es
Priority to PT04715239T priority patent/PT1604683E/pt
Priority to CNB2004800052015A priority patent/CN100418576C/zh
Priority to UAA200508381A priority patent/UA80859C2/xx
Priority to US10/547,164 priority patent/US8591917B2/en
Priority to YUP-2005/0664A priority patent/RS20050664A/sr
Priority to AU2004216554A priority patent/AU2004216554B2/en
Priority to NZ541952A priority patent/NZ541952A/en
Priority to BRPI0407854-3A priority patent/BRPI0407854B1/pt
Priority to DE602004004768T priority patent/DE602004004768T2/de
Priority to EP04715239A priority patent/EP1604683B1/en
Priority to AT04715239T priority patent/ATE353668T1/de
Priority to SI200430262T priority patent/SI1604683T1/sl
Priority to GEAP20048952A priority patent/GEP20074120B/en
Priority to PCT/CU2004/000003 priority patent/WO2004075811A2/es
Priority to ES04715239T priority patent/ES2280948T3/es
Priority to KR1020057015531A priority patent/KR100703570B1/ko
Priority to CA2535214A priority patent/CA2535214C/en
Priority to DK04715239T priority patent/DK1604683T3/da
Priority to EA200501367A priority patent/EA008905B1/ru
Priority to JP2006501455A priority patent/JP4729475B2/ja
Priority to IL170355A priority patent/IL170355A/en
Priority to EGPCTNA2005000479A priority patent/EG26446A/en
Priority to EC2005005978A priority patent/ECSP055978A/es
Priority to CR7965A priority patent/CR7965A/es
Priority to TNP2005000209A priority patent/TNSN05209A1/en
Priority to LVP-05-110A priority patent/LV13400B/en
Priority to HR20050763A priority patent/HRP20050763A2/hr
Priority to LT2005087A priority patent/LT5351B/lt
Priority to HK06107889.3A priority patent/HK1087630A1/xx
Priority to CY20071100556T priority patent/CY1106668T1/el
Publication of CU23257A1 publication Critical patent/CU23257A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/001171—Gangliosides, e.g. GM2, GD2 or GD3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se describen composiciones vacunales donde se combinan gangliosidos y el complejo de proteínas de membrana externa (CPME) de N. meningitidis para formar proteoliposomas de muy pequeno tamano (VSSP) que estAn destinadas a la administracion subcutAnea. Esta composiciones no requieren del empleo adicional de adyuvantes. Las composiciones descritas permiten tratamientos inmunologicos con gangliosidos, especialmente N-AcGM3/VSSP y N-GcGM3/VSSP, que presentan ventajas debido a que son menos agresivas en el lugar de la inyeccion, y pueden ser utilizadas de manera mAs simple y con menos molestias para los pacientes.
CU20030047A 2003-02-27 2003-02-27 COMPOSICIONES VACUNALES A BASE DE GANGLIOSIDOS PARA LA ADMINISTRACION SUBCUTáNEA CU23257A1 (es)

Priority Applications (37)

Application Number Priority Date Filing Date Title
CU20030047A CU23257A1 (es) 2003-02-27 2003-02-27 COMPOSICIONES VACUNALES A BASE DE GANGLIOSIDOS PARA LA ADMINISTRACION SUBCUTáNEA
ARP040100571A AR043377A1 (es) 2003-02-27 2004-02-24 Composiciones vacunales a base de gangliosidos para administracion subcutanea
PE2004000186A PE20040955A1 (es) 2003-02-27 2004-02-24 Composiciones vacunales a base de gangliosidos para administracion subcutanea
TW093104808A TWI344372B (en) 2003-02-27 2004-02-25 Ganglioside based vaccine compositions for subcutaneous administration
CL200400374A CL2004000374A1 (es) 2003-02-27 2004-02-26 Composicion de vacuna que comprende una disolucion o dispersion acuosa de uno a mas gangliosidos incluidos en vssp sin adyuvantes que estimulan la respuesta inmunologica.
MYPI20040641A MY139811A (en) 2003-02-27 2004-02-26 Subcutaneously - administered ganglioside-based vaccine compositions
UY28207A UY28207A1 (es) 2003-02-27 2004-02-27 Composiciones vacunales a base de gangliósidos para administración subcutánea.
PT04715239T PT1604683E (pt) 2003-02-27 2004-02-27 Composições de vacina subcutaneamente administradas tendo por base gangliósido
CNB2004800052015A CN100418576C (zh) 2003-02-27 2004-02-27 用于皮下施用的基于神经节苷脂的疫苗组合物
UAA200508381A UA80859C2 (en) 2003-02-27 2004-02-27 Ganglioside based vaccine composition for subcutaneous administration without the use of adjuvants
US10/547,164 US8591917B2 (en) 2003-02-27 2004-02-27 Ganglioside based vaccine compositions for subcutaneous administration
YUP-2005/0664A RS20050664A (en) 2003-02-27 2004-02-27 Subcutaneosly-administred ganglioside-based vaccine compositions
AU2004216554A AU2004216554B2 (en) 2003-02-27 2004-02-27 Subcutaneously-administered ganglioside-based vaccine compositions
NZ541952A NZ541952A (en) 2003-02-27 2004-02-27 Subcutaneously-administered ganglioside-based vaccine compositions
BRPI0407854-3A BRPI0407854B1 (pt) 2003-02-27 2004-02-27 Composição de vacina que compreende uma solução ou dispersão aquosa de um ou mais gangliosídeos incluídos em vssp
DE602004004768T DE602004004768T2 (de) 2003-02-27 2004-02-27 Subkutan verabreichte impfstoffzusammensetzungen auf gangliosidbasis
EP04715239A EP1604683B1 (en) 2003-02-27 2004-02-27 Subcutaneously-administered ganglioside-based vaccine compositions
AT04715239T ATE353668T1 (de) 2003-02-27 2004-02-27 Subkutan verabreichte impfstoffzusammensetzungen auf gangliosidbasis
SI200430262T SI1604683T1 (sl) 2003-02-27 2004-02-27 Vakcinski pripravki na gangliozidni osnovi za subkutano dajanje
GEAP20048952A GEP20074120B (en) 2003-02-27 2004-02-27 Subcutaneously-administered ganglioside-based vaccine compositions
PCT/CU2004/000003 WO2004075811A2 (es) 2003-02-27 2004-02-27 Composiciones vacunales a base de gangliósidos para administración subcutánea
ES04715239T ES2280948T3 (es) 2003-02-27 2004-02-27 Composiciones de vacunas basadas en gangliosidos para administracion por via subcutanea.
KR1020057015531A KR100703570B1 (ko) 2003-02-27 2004-02-27 피하 투여용 갱글리오사이드 기재 백신 조성물
CA2535214A CA2535214C (en) 2003-02-27 2004-02-27 Ganglioside based vaccine compositions for subcutaneous administration
DK04715239T DK1604683T3 (da) 2003-02-27 2004-02-27 Gangliogsid-baserede vaccinesammensætninger til subkutan administration
EA200501367A EA008905B1 (ru) 2003-02-27 2004-02-27 Вакцинная композиция на основе ганглиозидов для подкожного введения
JP2006501455A JP4729475B2 (ja) 2003-02-27 2004-02-27 皮下投与型ガングリオシド系ワクチン組成物
IL170355A IL170355A (en) 2003-02-27 2005-08-18 Ganglioside based vaccine compositions for subcutaneous administration
EGPCTNA2005000479A EG26446A (en) 2003-02-27 2005-08-20 Vaccine formulations based on gangliosides are free of adjuvants for subcutaneous administration
EC2005005978A ECSP055978A (es) 2003-02-27 2005-08-24 Composiciones vacunales a base de gangliósidos para administración subcutánea
CR7965A CR7965A (es) 2003-02-27 2005-08-26 Composiciones vacunales a base de gangliosidos para administracion subcutanea
TNP2005000209A TNSN05209A1 (en) 2003-02-27 2005-08-26 Ganglioside based vaccine compositions for subcutaneous administration
LVP-05-110A LV13400B (en) 2003-02-27 2005-08-29 Subcutaneously-administered ganglioside-based vaccine compositions
HR20050763A HRP20050763A2 (en) 2003-02-27 2005-09-02 Ganglioside based vaccine compositions for subcutaneous administration
LT2005087A LT5351B (lt) 2003-02-27 2005-09-21 Vakcinos kompozicijos gangliozido pagrindu, skirtos įvedimui po oda
HK06107889.3A HK1087630A1 (en) 2003-02-27 2006-07-14 Subcutaneously-administered ganglioside-based vaccine compositions
CY20071100556T CY1106668T1 (el) 2003-02-27 2007-04-26 Υποδοριως χορηγουμενες συνθεσεις εμβολιου βασης γαγγλιοζιτη

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20030047A CU23257A1 (es) 2003-02-27 2003-02-27 COMPOSICIONES VACUNALES A BASE DE GANGLIOSIDOS PARA LA ADMINISTRACION SUBCUTáNEA

Publications (1)

Publication Number Publication Date
CU23257A1 true CU23257A1 (es) 2008-01-24

Family

ID=40091613

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20030047A CU23257A1 (es) 2003-02-27 2003-02-27 COMPOSICIONES VACUNALES A BASE DE GANGLIOSIDOS PARA LA ADMINISTRACION SUBCUTáNEA

Country Status (37)

Country Link
US (1) US8591917B2 (es)
EP (1) EP1604683B1 (es)
JP (1) JP4729475B2 (es)
KR (1) KR100703570B1 (es)
CN (1) CN100418576C (es)
AR (1) AR043377A1 (es)
AT (1) ATE353668T1 (es)
AU (1) AU2004216554B2 (es)
BR (1) BRPI0407854B1 (es)
CA (1) CA2535214C (es)
CL (1) CL2004000374A1 (es)
CR (1) CR7965A (es)
CU (1) CU23257A1 (es)
CY (1) CY1106668T1 (es)
DE (1) DE602004004768T2 (es)
DK (1) DK1604683T3 (es)
EA (1) EA008905B1 (es)
EC (1) ECSP055978A (es)
EG (1) EG26446A (es)
ES (1) ES2280948T3 (es)
GE (1) GEP20074120B (es)
HK (1) HK1087630A1 (es)
HR (1) HRP20050763A2 (es)
IL (1) IL170355A (es)
LT (1) LT5351B (es)
LV (1) LV13400B (es)
MY (1) MY139811A (es)
NZ (1) NZ541952A (es)
PE (1) PE20040955A1 (es)
PT (1) PT1604683E (es)
RS (1) RS20050664A (es)
SI (1) SI1604683T1 (es)
TN (1) TNSN05209A1 (es)
TW (1) TWI344372B (es)
UA (1) UA80859C2 (es)
UY (1) UY28207A1 (es)
WO (1) WO2004075811A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU24534B1 (es) * 2017-11-06 2021-07-02 Ct Inmunologia Molecular Adyuvantes nano-particulados que contienen variantes sintéticas del gangliósido gm3
CU20170173A7 (es) 2017-12-27 2019-11-04 Ct Inmunologia Molecular Nano-partículas que contienen el gangliósido gm3 como inmunomoduladoras

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965198A (en) 1985-12-24 1990-10-23 Konica Corporation Monoclonal antibody and method of manufacturing hybridoma producing the same
US6149921A (en) * 1993-12-29 2000-11-21 Centro De Inmunologia Molecular Vaccine compositions for eliciting an immune response against N-acetylated gangliosides and their use for cancer treatment
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
PE20020572A1 (es) * 2000-12-06 2002-07-31 Centro Inmunologia Molecular Preparaciones para potenciar la inmunogenicidad de antigenos poco inmunogenicos
EP1293212A1 (en) * 2001-08-21 2003-03-19 National Research Council Of Canada Anti cancer vaccine comprising whole cancer cells with modified sialic acid

Also Published As

Publication number Publication date
BRPI0407854A (pt) 2006-02-14
WO2004075811A3 (es) 2004-10-14
BRPI0407854B1 (pt) 2019-02-26
CR7965A (es) 2008-10-29
EG26446A (en) 2013-11-07
NZ541952A (en) 2008-06-30
AU2004216554B2 (en) 2010-05-20
CN100418576C (zh) 2008-09-17
WO2004075811A2 (es) 2004-09-10
US8591917B2 (en) 2013-11-26
PE20040955A1 (es) 2005-02-03
DE602004004768D1 (de) 2007-03-29
EP1604683A2 (en) 2005-12-14
PT1604683E (pt) 2007-05-31
US20070148181A1 (en) 2007-06-28
TWI344372B (en) 2011-07-01
EA008905B1 (ru) 2007-08-31
RS20050664A (en) 2007-11-15
CA2535214A1 (en) 2004-09-10
MY139811A (en) 2009-10-30
EA200501367A1 (ru) 2006-02-24
CN1753691A (zh) 2006-03-29
UY28207A1 (es) 2004-09-30
HK1087630A1 (en) 2006-10-20
DK1604683T3 (da) 2007-06-11
DE602004004768T2 (de) 2007-10-11
HRP20050763A2 (en) 2006-06-30
KR100703570B1 (ko) 2007-04-09
AR043377A1 (es) 2005-07-27
SI1604683T1 (sl) 2007-08-31
ECSP055978A (es) 2006-01-16
LV13400B (en) 2006-05-20
CA2535214C (en) 2012-01-10
UA80859C2 (en) 2007-11-12
JP4729475B2 (ja) 2011-07-20
AU2004216554A1 (en) 2004-09-10
CL2004000374A1 (es) 2005-05-06
LT5351B (lt) 2006-07-25
EP1604683B1 (en) 2007-02-14
CY1106668T1 (el) 2012-05-23
ATE353668T1 (de) 2007-03-15
LT2005087A (en) 2006-04-25
TNSN05209A1 (en) 2007-06-11
GEP20074120B (en) 2007-05-25
IL170355A (en) 2010-05-31
JP2006519186A (ja) 2006-08-24
ES2280948T3 (es) 2007-09-16
KR20060003857A (ko) 2006-01-11

Similar Documents

Publication Publication Date Title
AR100225A2 (es) Anticuerpos anti-factor d humanizados y usos de los mismos
NI202100050A (es) Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
ECSP10010723A (es) Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso
AR042795A1 (es) Fluidos de dialisis biocompatibles que contienen icodextrinas
AR057946A1 (es) Formulacion de zonisamida de liberacion sostenidda
AR054844A1 (es) Vacuna contra lawsonia y metodos de uso de la misma
ECSP034787A (es) Combinaciones inmunoterapeuticas para el tratamiento de tumores que sobre expresan gangliosidos
BRPI0516247A (pt) métodos de tratamento hormonal, utilizando regimes de ciclo prolongado de dose crescente
PE20150226A1 (es) Agentes terapeuticos para administracion subcutanea optimizados
PE20211199A1 (es) Uso de reboxetina para el tratamiento de narcolepsia
ES2525009T3 (es) Glucoproteínas que tienen propiedades de movilización de lípidos y usos terapéuticos de las mismas
AR091977A1 (es) El uso de antitrombina en la oxigenacion de membranas extracorporeas
ECSP055978A (es) Composiciones vacunales a base de gangliósidos para administración subcutánea
BR112015024402A2 (pt) suporte de paciente
AR097172A1 (es) Composiciones vacunales bivalentes y su uso para la terapia de tumores
RU2008144180A (ru) Вакцина против микоплазмы и prrsv
AR027738A1 (es) Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas
RU2007141393A (ru) Способ лечения спастического и болевого синдромов у пациентов с последствиями позвоночно-спинномозговой травмы
Louis et al. A Picture Worth A Thousand Words-Using Chairside Cellphone Pictures to Aid in Visualization of Treatment
Villalobos The implementation in the operative level of the nursing process
Drey et al. Gingival conditioning technique in prosthetic rehabilitation: a case report
Price et al. Understanding the search for patients' well-being in a program of hypertension
ABEL Looking back into the Beer-Jaeger family
Cear Vacunas de rickettsias